Long-term Effects of Inspiratory Muscle Training in Chronic Venous Insufficiency

May 16, 2025 updated by: Gulsah Bargi, Izmir Democracy University

Long-term Effects of Inspiratory Muscle Training in Individuals With Chronic Venous Insufficiency

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. For this reason, in this study, it was aimed to investigate the long-term results of inspiratory muscle training in individuals with chronic venous insufficiency.

Study Overview

Detailed Description

Initial treatment of chronic venous insufficiency (CVI) includes conservative methods such as reducing symptoms and helping to prevent secondary problems and disease progression. If conservative methods fail, further treatments based on anatomical and physiological pathophysiological features should be applied. Treatment of CVI ranges from simple compression stockings to very complicated venous reconstructions. Physiotherapy applications also have an important place in the treatment of CVI and contain patient education, complex decongestive physiotherapy, intermittent pneumatic compression, compression garment, venous exercise programs, biomechanical stimulation therapy, proprioceptive neuromuscular facilitation, relaxation techniques and hydrotherapy methods.

Researches investigating the effectiveness of new physiotherapy applications in CVI are very limited. In one of these publications, the effects of inspiratory muscle training (IMT) and calf muscle exercise training (CMET) applied in addition to compression therapy (CT) on quality of life (QoL), venous filling time, disease severity, pain, edema, range of motion, muscle strength and functionality were investigated newly. IMT and CT were applied in group 1, CMET and CT were applied in group 2, and only CT was applied in group 3. As a result, groups of 1 and 2 showed more improvement in these outcomes compared to other groups. Acute effects of inspiratory muscle training in CVI was only shown in this study. The long-term effectiveness of inspiratory muscle training is still unclear in individuals with CVI. Therefore, this study aimed to investigate the long-term results of inspiratory muscle training in individuals with CVI.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey, 35140
        • Izmir Democracy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years of age or older
  • Volunteering to participate in the study
  • Diagnosed with chronic venous insufficiency using duplex ultrasound and being under standard medical treatment follow-up
  • Being in one of the C1, C2, C3, C4 or C5 stages according to the Clinical, Etiology, Anatomy and Pathophysiology (CEAP) classification

Exclusion Criteria:

  • Acute deep vein thrombosis, active ulcers, psychiatric disorder requiring prior vessel ablation and/or prescription drug therapy,
  • Any history of chronic disease or deep vein thrombosis that may interfere with exercise capacity measurement,
  • Having SARS-CoV-2 (COVID-19) or any acute infection,
  • Being pregnant,
  • History of arterial disease,
  • Having advanced cardiorespiratory diseases, acute ulcer (< 3 months) and diabetic ulcers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training group
The individuals in the training group will be performed inspiratory muscle training using an inspiratory muscle training device (PowerBreathe®) at 30-50% of the maximal inspiratory pressure.
The individuals in the training group will be performed inspiratory muscle training at 30-50% of the maximal inspiratory pressure. Inspiratory muscle training will be done using an inspiratory muscle training device (PowerBreathe®) that works with the threshold loading principle. Inspiratory muscle training will be done for 15 minutes per a session, 2 times per a day or, if tolerated, 30 minutes per a day and 1 time per a day, 5-7 days/week (one session under the supervision and the others at home), for a total of 6 weeks. Applications made at home will be followed with a diary.
Other Names:
  • Experimental: Training group
Sham Comparator: Control group
Individuals in the control group will be performed thoracic expansion exercises.
Individuals in the control group will be performed thoracic expansion exercises. Thoracic expansion exercises will be applied to individuals in an upright sitting position. In this position, individuals will place their hands on their lower ribs and then perform the cycle of "deep breathing + holding the deep breath for 3 seconds + slowly emptying all the breath" 3 times in a row. After this cycle, individuals will be asked to rest by taking 3-4 calm breaths. Immediately after, the individual will be asked to repeat the same cycle and repeat the cycle with calm breaths and rest until it reaches 10 repetitions. The individual will do this session 4 times a day. Individuals will do the first session of breathing exercises under supervision. In this way, incorrect exercise will be prevented. Other breathing exercise sessions will be done by individuals as a home program every day and 4 sessions a day during 6 weeks.
Other Names:
  • Sham Comparator: Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal inspiratory pressure (MIP)
Time Frame: After 6-week training and 3 months after 6-week training ends.
The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.
After 6-week training and 3 months after 6-week training ends.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal expiratory pressure (MEP)
Time Frame: After 6-week training and 3 months after 6-week training ends.
The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.
After 6-week training and 3 months after 6-week training ends.
Forced vital capacity (FVC)
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pulmonary function (Forced vital capacity (FVC)) will be evaluated with a spirometer.
After 6-week training and 3 months after 6-week training ends.
Forced expiratory volume in the first second (FEV1)
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pulmonary function (Forced expiratory volume in the first second (FEV1)) will be evaluated with a spirometer.
After 6-week training and 3 months after 6-week training ends.
FEV1 / FVC
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pulmonary function (FEV1 / FVC) will be evaluated with a spirometer.
After 6-week training and 3 months after 6-week training ends.
Flow rate 25-75% of forced expiratory volume (FEF 25-75%)
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) will be evaluated with a spirometer.
After 6-week training and 3 months after 6-week training ends.
Peak flow rate (PEF)
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pulmonary function (Peak flow rate (PEF)) will be evaluated with a spirometer.
After 6-week training and 3 months after 6-week training ends.
Pain Intensity measured with the Numerical Rating Scale.
Time Frame: After 6-week training and 3 months after 6-week training ends.
Pain intensity will be measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).
After 6-week training and 3 months after 6-week training ends.
Aerobic capacity
Time Frame: After 6-week training and 3 months after 6-week training ends.
The six-minute walk test (6-MWT) will be performed according to the criteria of the American Thoracic Society for the evaluation of aerobic capacity.
After 6-week training and 3 months after 6-week training ends.
Lower extremity strength
Time Frame: After 6-week training and 3 months after 6-week training ends.
To determine lower extremity strength and functional mobility, the 30-second Sit-Up Test will be used in the chair.
After 6-week training and 3 months after 6-week training ends.
Total quality of life score evaluated by Chronic Venous Disease Quality of Life Questionnaire
Time Frame: After 6-week training and 3 months after 6-week training ends.
The score will be evaluated using Chronic Venous Disease Quality of Life Questionnaire. Each question is scored on a 5-item Likert scale. Higher scores indicate better quality of life.
After 6-week training and 3 months after 6-week training ends.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: GÜLŞAH BARĞI, Assoc. Dr., Izmir Democracy University
  • Principal Investigator: ÖZLEM ÇİNAR ÖZDEMİR, Assoc. Dr., Izmir Democracy University
  • Principal Investigator: CEMRE GÖRÜNMEZOĞLU, MSc, Izmir Democracy University
  • Principal Investigator: DÜNDAR ÖZALP KARABAY, Prof. Dr., Dokuz Eylül University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2023

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

July 28, 2023

First Submitted That Met QC Criteria

August 5, 2023

First Posted (Actual)

August 8, 2023

Study Record Updates

Last Update Posted (Actual)

May 18, 2025

Last Update Submitted That Met QC Criteria

May 16, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Venous Insufficiency

Clinical Trials on Training group: Inspiratory muscle training

Subscribe